Panicos Shangaris: Is Chronic Histiocytic Intervillositis a Form of Maternal Anti Fetal Rejection?
Panicos Shangaris, Consultant in Obstetrics, Maternal, and Fetal Medicine at Central Health London, shared a post on LinkedIn about a paper puublished in Journal of Reproductive Immunology:
“Delighted to share our latest work on Chronic Histiocytic Intervillositis (CHI), a rare but devastating placental disorder with significant implications for pregnancy outcomes.
‘Chronic histiocytic intervillositis: Insights into immunopathogenesis and prospective treatments’
In this review, we explore:
- The emerging alloimmune hypothesis: is CHI a form of maternal anti-fetal rejection?
- Key immunological pathways, including complement activation, CD8+ T cells, and inflammasomes
- The role of anti-HLA antibodies and abnormal HLA expression
- Why current treatments remain limited — and where future therapies may lie
CHI remains under-recognised, often diagnosed only after pregnancy loss, and carries a high recurrence risk. A deeper understanding of its biology is essential if we are to move toward earlier diagnosis, personalised care, and prevention.
Grateful to collaborate with an outstanding multidisciplinary team across fetal medicine and immunology.”
Title: Chronic histiocytic intervillositis: Insights into Immunopathogenesis and prospective treatments
Authors: Morgan Jean Bell-Ricketts, Imogen Alice Porter-Wright, Katrina Borovika, Amanda Bowman, Giovanna Lombardi, Kypros H Nicolaides, María Teresa Martín Monreal, Panicos Shangaris
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Apr 17, 2026, 04:19WHO Raises Alarm Over Global Burden of Child Marriage
-
Apr 17, 2026, 04:11Sign Up for Our Latest BFS Insights Webinar – British Fertility Society
-
Apr 17, 2026, 03:43Chantelle Pereira: Endometriosis Paper Highlights Diagnostic Delays and Gaps in Patient Care
-
Apr 17, 2026, 03:35Tal Varsano: Plasma Proteomic Signature of the Human Menstrual Cycle
-
Apr 17, 2026, 03:30Vacancy for a Friendly Senior Embryologist in Berlin, Germany – ESHRE
-
Apr 17, 2026, 03:05Clinical Study Supports Continued IVF After Unsuccessful First Transfer – RBMO
-
Apr 17, 2026, 02:57Standing Together for Black Maternal Health Week – ACOG
-
Apr 16, 2026, 17:24No Difference Between Natural and Artificial Cycles in Endometrium Cases – RBMO
-
Apr 16, 2026, 17:20Marco Zaccaria: Recognizing Innovation in Adenomyosis Treatment